CLINICAL OUTCOMES STUDIES 

a) Improving maternal and neonatal outcomes in IBD with a dedicated clinic: We hope to show that a dedicated clinical follow up and counselling can improve outcomes for mothers with IBD and their infants. This study is being conducted out of University of Alberta, Edmonton.

b) Quality of Life in pregnancy in women with IBD: We are studying how pregnancy may affect the quality of life for pregnant women with IBD. This study is being conducted out of University of Alberta, Edmonton.

c) Medication adherence during pregnancy in women with IBD: We hope to show that a dedicated clinic with routine clinical follow up and counselling can improve medication adherence. This study is being conducted out of University of Alberta, Edmonton.

d) Biomarkers for predicting IBD disease activity in pregnancy and IBD:   We are studying the fecal calprotectin (FCP) stool test, which should ONLY be elevated from inflammation in the intestines, to see if it can help guide the management of IBD during pregnancy. This study is being conducted out of University of Alberta, Edmonton.